![Martin Godbout](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Martin Godbout
Fundador en
BioContact (Québec), Inc.
.
Perfil
Martin Godbout is the founder of BioContact (Québec), Inc. (founded in 1994) and Genome Canada (founded in 2000).
He is currently a Director at Angiochem, Inc., Fonds Recherche sur Nature et les Technologies, Ataxia of Charlevoix-Saguenay Foundation, Montreal Invivo Organization, Fondation Sur Les Leucodystrophies, and Corporation Inno-centre du Québec.
He is also the President of Hodran Consultants, Inc. (since 2009).
Dr. Godbout has held former positions as Chairman of BioQuebec, Génome Québec, Inc., and Insitut de Recherche en Immunologie et en Cancérologie.
He was also a Director at Acasti Pharma, Inc. (2011), BioCapital Investment Advisors, Inc. (2003-2005), Mirati Therapeutics, Inc. (2002-2014), Asmacure Ltée, Conseil de la Science et de la Technologie du Québec (1996-2004), AmorChem Financial, Inc., and Senior Vice President at BioCapital Investment Advisors, Inc. He served as President & General Manager of Société Innovatech du Grand Montréal and holds the title of Principal at Order of Canada.
Dr. Godbout received his undergraduate degree from Université Laval in 1979 and holds a doctorate from the same institution.
Cargos activos de Martin Godbout
| Empresas | Cargo | Inicio |
|---|---|---|
Angiochem, Inc.
 Angiochem, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for brain diseases | Director/Miembro de la Junta | - |
BioContact (Québec), Inc.
 BioContact (Québec), Inc. Medical/Nursing ServicesHealth Services Operates as a pharmaceutical partnership symposium which specializes in medicinal chemistry and the custom synthesis of small molecules and peptides | Fundador | 05/01/2010 |
Ataxia of Charlevoix-Saguenay Foundation | Director/Miembro de la Junta | - |
Hodran Consultants, Inc. | Presidente | 01/10/2009 |
Montreal Invivo Organization
 Montreal Invivo Organization Montreal Invivo Organization is a non-profit company based in Montréal, Canada. | Director/Miembro de la Junta | - |
Fonds Recherche sur Nature et les Technologies | Director/Miembro de la Junta | - |
Fondation Sur Les Leucodystrophies
 Fondation Sur Les Leucodystrophies Miscellaneous Commercial ServicesCommercial Services Offers leukodystrophy treatment services for children | Director/Miembro de la Junta | - |
Corporation Inno-centre du Québec
 Corporation Inno-centre du Québec Investment ManagersFinance Provides financial consulting and marketing services | Director/Miembro de la Junta | 11/06/2015 |
Antiguos cargos conocidos de Martin Godbout.
| Empresas | Cargo | Fin |
|---|---|---|
| MIRATI THERAPEUTICS | Presidente | 23/07/2013 |
| ░░░░░░ ░░░░░░ | ░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░ ░░░ ░░░░░░░ ░░ ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░ ░░ ░░░░░░░ ░░ ░░ ░░ ░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░ ░░░░░░░░░ ░░ ░░░░░░░░░░░ ░░ ░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Formación de Martin Godbout.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
71
Relaciones de 1er grado
21
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 21 |
|---|---|
Grace Therapeutics, Inc.
 Grace Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for rare and orphan diseases | Health Technology |
BioCapital Investment Advisors, Inc.
 BioCapital Investment Advisors, Inc. Investment ManagersFinance The fundamental investment objective of BioCapital is to provide investors superior capital appreciation by investing in equity securities of public companies with high growth potential in biotechnology industries. They seek to achieve this fundamental objective by investing in a diversified portfolio of public companies primarily in the following sectors of the biotechnology industry: therapeutics in the fields of cancer, cardiology, infectious diseases, immune system and central nervous system. The firm also invests in companies developing platform technologies in the fields on genomics and proteomics, drug delivery, theranostics, nanotechnology and monoclonal antibody. | Finance |
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
Angiochem, Inc.
Angiochem, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for brain diseases | Health Technology |
Société Innovatech du Grand Montréal | |
Université Laval
 Université Laval Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Asmacure Ltée
 Asmacure Ltée Pharmaceuticals: MajorHealth Technology Develops novel, proprietary compounds that target cholinergic receptors for the treatment of inflammation, notably pulmonary airway diseases | Health Technology |
BioQuebec
 BioQuebec BiotechnologyHealth Technology Manufactures biotech products | Health Technology |
Order of Canada
 Order of Canada Miscellaneous Commercial ServicesCommercial Services Honorary society | Commercial Services |
Genome Canada
 Genome Canada Miscellaneous Commercial ServicesCommercial Services Provides genomic research services | Commercial Services |
BioContact (Québec), Inc.
BioContact (Québec), Inc. Medical/Nursing ServicesHealth Services Operates as a pharmaceutical partnership symposium which specializes in medicinal chemistry and the custom synthesis of small molecules and peptides | Health Services |
Génome Québec, Inc.
 Génome Québec, Inc. Miscellaneous Commercial ServicesCommercial Services Develops genomics and DNA in Quebec | Commercial Services |
Conseil de la Science et de la Technologie du Québec
 Conseil de la Science et de la Technologie du Québec General GovernmentGovernment Advisory commission on science and technology | Government |
Fonds Recherche sur Nature et les Technologies | |
Ataxia of Charlevoix-Saguenay Foundation | |
Montreal Invivo Organization
Montreal Invivo Organization Montreal Invivo Organization is a non-profit company based in Montréal, Canada. | |
Hodran Consultants, Inc. | |
Fondation Sur Les Leucodystrophies
Fondation Sur Les Leucodystrophies Miscellaneous Commercial ServicesCommercial Services Offers leukodystrophy treatment services for children | Commercial Services |
AmorChem Financial, Inc.
 AmorChem Financial, Inc. Financial ConglomeratesFinance Provides financial investment services | Finance |
Insitut de Recherche en Immunologie et en Cancérologie
 Insitut de Recherche en Immunologie et en Cancérologie Miscellaneous Commercial ServicesCommercial Services Engages in research and development in immunology and cancer | Commercial Services |
Corporation Inno-centre du Québec
Corporation Inno-centre du Québec Investment ManagersFinance Provides financial consulting and marketing services | Finance |
- Bolsa de valores
- Insiders
- Martin Godbout
